CIK 0001672688 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Absci Corp
Sign in to watch- Ticker
- ABSI
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 853383487
- Phone
- (360) 949-1041
- Business address
- 18105 SE MILL PLAIN BLVD, VANCOUVER, WA, 98683
- Former names
- AbSci, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 40 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Bedrick Todd SVP, CAO | Grant or award · Stock Option (right to buy) | +195,900 | 195,900 | ||
| 2026-03-02 | McClain Sean Chief Executive Officer | Grant or award | +406,200 | 8,740,767 | ||
| 2026-03-02 | McClain Sean Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,603,200 | 1,603,200 | ||
| 2026-03-02 | Pangalos Menelas N Director | Grant or award | +5,800 | 194,855 | ||
| 2026-03-02 | Pangalos Menelas N Director | Grant or award · Stock Option (right to buy) | +22,800 | 22,800 | ||
| 2026-03-02 | Walker Shelby J. Chief Legal Officer | Grant or award | +90,300 | 149,600 | ||
| 2026-03-02 | Walker Shelby J. Chief Legal Officer | Grant or award · Stock Option (right to buy) | +356,300 | 356,300 | ||
| 2026-03-02 | McClain Sean Chief Executive Officer | Grant or award | +406,200 | 8,740,767 | ||
| 2026-03-02 | McClain Sean Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,603,200 | 1,603,200 | ||
| 2026-03-02 | Bedrick Todd SVP, CAO | Grant or award | +49,600 | 222,224 | ||
| 2026-03-02 | Bedrick Todd SVP, CAO | Grant or award · Stock Option (right to buy) | +195,900 | 195,900 | ||
| 2026-03-02 | Jonasson Zachariah CFO / CBO | Grant or award | +135,400 | 510,631 | ||
| 2026-03-02 | Jonasson Zachariah CFO / CBO | Grant or award · Stock Option (right to buy) | +534,400 | 534,400 | ||
| 2026-03-02 | Jonasson Zachariah CFO / CBO | Shares withheld for taxes | −8,307 | $2.74 | $23K | 375,231 |
| 2026-02-27 | Pangalos Menelas N Director | Purchase | +75,095 | $2.74 | $206K | 189,055 |
| 2026-02-23 | McClain Sean Chief Executive Officer | Option exercise | +396,399 | $1.21 | $480K | 8,730,966 |
| 2026-02-23 | McClain Sean Chief Executive Officer | Shares withheld for taxes | −267,008 | $2.65 | $708K | 8,463,958 |
| 2026-02-23 | McClain Sean Chief Executive Officer | Option exercise · Stock Option (right to buy) | −396,399 | 0 | ||
| 2026-02-03 | Busch Andreas Chief Innovation Officer | Shares withheld for taxes | −1,469 | $2.99 | $4K | 322,703 |
| 2026-02-02 | Jonasson Zachariah CFO / CBO | Shares withheld for taxes | −17,496 | $2.99 | $52K | 383,538 |
Page 3 of 8 · 154 trades